FDA Center for Drug Evaluation & Research Issues Warning Letter to LGM Pharma Solutions
November 18, 2026
November 18, 2026
WASHINGTON, Nov. 18 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to LGM Pharma Solutions LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Prasad Raje, Chief Executive Officer, LGM Pharma Solutions, LLC, 6400 Congress Ave., Suite 1400, Boca Raton, FL 33487, United States
(b)(6)
Issuing Office: Center for Drug Evaluation and Research (CDER) . . .
* * *
Recipient: Mr. Prasad Raje, Chief Executive Officer, LGM Pharma Solutions, LLC, 6400 Congress Ave., Suite 1400, Boca Raton, FL 33487, United States
(b)(6)
Issuing Office: Center for Drug Evaluation and Research (CDER) . . .
